Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

What is the role of screening for pulmonary hypertension in adults and children with sickle cell disease?

Willen SM, Gladwin MT.

Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):431-434. doi: 10.1182/asheducation-2017.1.431. Review.

PMID:
29222289
2.

Misclassification of pulmonary hypertension in adults with sickle hemoglobinopathies using Doppler echocardiography.

Fitzgerald M, Fagan K, Herbert DE, Al-Ali M, Mugal M, Haynes J Jr.

South Med J. 2012 Jun;105(6):300-5. doi: 10.1097/SMJ.0b013e318256b55b.

PMID:
22665152
3.

Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease.

Pashankar FD, Carbonella J, Bazzy-Asaad A, Friedman A.

Pediatrics. 2008 Apr;121(4):777-82. doi: 10.1542/peds.2007-0730.

PMID:
18381543
4.

Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation.

Minniti CP, Sable C, Campbell A, Rana S, Ensing G, Dham N, Onyekwere O, Nouraie M, Kato GJ, Gladwin MT, Castro OL, Gordeuk VR.

Haematologica. 2009 Mar;94(3):340-7. doi: 10.3324/haematol.13812. Epub 2009 Feb 11.

5.

Serum apelin as a novel non-invasive marker for subclinical cardiopulmonary complications in children and adolescents with sickle cell disease.

Elbarbary NS, Ismail EA, Roushdy A, Fahmy E.

Blood Cells Mol Dis. 2016 Mar;57:1-7. doi: 10.1016/j.bcmd.2015.11.001. Epub 2015 Nov 10.

PMID:
26852648
6.

Pulmonary hypertension in children and adolescents with sickle cell disease.

Onyekwere OC, Campbell A, Teshome M, Onyeagoro S, Sylvan C, Akintilo A, Hutchinson S, Ensing G, Gaskin P, Kato G, Rana S, Kwagyan J, Gordeuk V, Williams J, Castro O.

Pediatr Cardiol. 2008 Mar;29(2):309-12. Epub 2007 Aug 7.

PMID:
17680298
7.

Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease.

Ambrusko SJ, Gunawardena S, Sakara A, Windsor B, Lanford L, Michelson P, Krishnamurti L.

Pediatr Blood Cancer. 2006 Dec;47(7):907-13.

PMID:
16496290
9.

A hemodynamic study of pulmonary hypertension in sickle cell disease.

Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G, Habibi A, Bennani S, Savale L, Adnot S, Maitre B, Yaïci A, Hajji L, O'Callaghan DS, Clerson P, Girot R, Galacteros F, Simonneau G.

N Engl J Med. 2011 Jul 7;365(1):44-53. doi: 10.1056/NEJMoa1005565.

10.

Prospective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease.

Dham N, Ensing G, Minniti C, Campbell A, Arteta M, Rana S, Darbari D, Nouraie M, Onyekwere O, Lasota M, Kato GJ, Gladwin MT, Castro O, Gordeuk V, Sable C.

Am J Cardiol. 2009 Sep 1;104(5):713-20. doi: 10.1016/j.amjcard.2009.04.034. Epub 2009 Jun 24.

11.

N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.

Mokhtar GM, Adly AA, El Alfy MS, Tawfik LM, Khairy AT.

Hemoglobin. 2010;34(1):78-94. doi: 10.3109/03630260903554621.

PMID:
20113292
12.

Paediatric sickle cell disease: pulmonary hypertension but normal vascular resistance.

Chaudry RA, Cikes M, Karu T, Hutchinson C, Ball S, Sutherland G, Rosenthal M, Bush A, Crowley S.

Arch Dis Child. 2011 Feb;96(2):131-6. doi: 10.1136/adc.2010.184028. Epub 2010 Oct 27.

PMID:
21030373
13.

Elevated tricuspid regurgitant velocity as a marker for pulmonary hypertension in children with sickle cell disease: less prevalent and predictive than previously thought?

Hebson C, New T, Record E, Oster M, Ehrlich A, Border W, James-Herry A, Kanaan U.

J Pediatr Hematol Oncol. 2015 Mar;37(2):134-9. doi: 10.1097/MPH.0000000000000184.

PMID:
24942020
14.

Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease.

Niss O, Quinn CT, Lane A, Daily J, Khoury PR, Bakeer N, Kimball TR, Towbin JA, Malik P, Taylor MD.

JACC Cardiovasc Imaging. 2016 Mar;9(3):243-52. doi: 10.1016/j.jcmg.2015.05.013. Epub 2016 Feb 17. Review.

15.

An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.

Klings ES, Machado RF, Barst RJ, Morris CR, Mubarak KK, Gordeuk VR, Kato GJ, Ataga KI, Gibbs JS, Castro O, Rosenzweig EB, Sood N, Hsu L, Wilson KC, Telen MJ, Decastro LM, Krishnamurti L, Steinberg MH, Badesch DB, Gladwin MT; American Thoracic Society Ad Hoc Committee on Pulmonary Hypertension of Sickle Cell Disease.

Am J Respir Crit Care Med. 2014 Mar 15;189(6):727-40. doi: 10.1164/rccm.201401-0065ST.

16.

A modified noninvasive screening protocol for pulmonary hypertension in children with sickle cell disease-Who should be sent for invasive evaluation?

Lilje C, Harry J, Gajewski KK, Gardner RV.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26606. Epub 2017 May 5.

PMID:
28475298
17.

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP.

N Engl J Med. 2004 Feb 26;350(9):886-95.

18.

Pulmonary hypertension in sickle cell disease: relevance to children.

Kato GJ, Onyekwere OC, Gladwin MT.

Pediatr Hematol Oncol. 2007 Apr-May;24(3):159-70. Review.

19.

Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity.

El-Shanshory M, Badraia I, Donia A, Abd El-Hameed F, Mabrouk M.

Eur J Haematol. 2013 Jul;91(1):55-61. doi: 10.1111/ejh.12114. Epub 2013 May 3.

PMID:
23551575
20.

Hemodynamic characteristics and predictors of pulmonary hypertension in patients with sickle cell disease.

Caughey MC, Hinderliter AL, Jones SK, Shah SP, Ataga KI.

Am J Cardiol. 2012 May 1;109(9):1353-7. doi: 10.1016/j.amjcard.2011.11.067. Epub 2012 Feb 15.

Supplemental Content

Support Center